MCD vs NRIX · P/E 23, rev $25.92B vs rev $54.5M
McDonald’s Corporation (MCD) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the MCD and NRIX stock pages for the full models.
Not investment advice.